Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
70 hedge funds and large institutions have $30.8M invested in Avid Bioservices, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 11 closing their positions.
127% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 11
90% more call options, than puts
Call options by funds: $226K | Put options by funds: $119K
47% more capital invested
Capital invested by funds: $21M → $30.8M (+$9.79M)
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
25% more funds holding
Funds holding: 56 → 70 (+14)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$8.08M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.6M |
| 3 |
SIC
Schwartz Investment Counsel
Plymouth,
Michigan
|
+$1.47M |
| 4 |
BP
Bandera Partners
New York
|
+$1.26M |
| 5 |
Millennium Management
New York
|
+$553K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$697K |
| 2 |
PP
PDT Partners
New York
|
-$260K |
| 3 |
BAS
Brown Advisory Securities
Baltimore,
Maryland
|
-$149K |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$119K |
| 5 |
Morgan Stanley
New York
|
-$116K |
CDMO Hedge Fund Activity: Q1 2018 in Review
70 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2018, worth a combined $30.8M — up 47% from $21M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new CDMO positions and 11 closed out — a net gain of 14 holders — while 17 added to existing stakes and 13 trimmed.
The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $8.08M. The largest seller was Geode Capital Management, cutting an estimated $697K.
- 70 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2018, up from 56 in Q4 2017.
- Funds reported $30.8M of Avid Bioservices, Inc. Common Stock stock for Q1 2018, up 47% quarter-over-quarter.
- 25 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2018 and 11 closed out, a net change of +14 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2018 was Kennedy Capital Management, an estimated $8.08M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2018 was Geode Capital Management, an estimated $697K sold.
Based on aggregated 13F filings for Q1 2018.